Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Bimatoprost + Timolol
Ganfort
Routinely available
SMC (312/06)
22/04/2015
Indication
Reduction of intraocular pressure in patients with open-angle glaucoma or ocular hyper
Therapeutic Area
Eye
Status Description
Routinely available in line with national guidance
Formulation
0.03%/0.5% eye drops
Comments
August 2008 - ‘Not preferred’ as suitable alternatives exist. April 2015 - Included in the prescribing notes. July 2019 (as per LJF) - Routinely available in line with national guidance. Included in the LJF.
Link to Advice
Advice Published
09/10/2006
SMC Submission Type
Abbreviated
SMC Status
Accepted